Dr. Kastellorizios is an Assistant Professor of Pharmaceutical Sciences at the University of North Texas Health Science Center, College of Pharmacy. He received a Bachelor’s degree in Pharmacy and a Master’s degree in Industrial Pharmaceutics from the University of Patras, Greece, and a PhD in Pharmaceutics from the University of Connecticut. After receiving his PhD, he worked as a Postdoctoral Fellow at the University of Connecticut on in vitro dissolution method development and bioequivalence studies of in situ forming implants. Prior to his current position he was the Director of R&D at a medical device startup (Biorasis, Inc.) where he led the research and development efforts to advance the company’s continuous glucose monitoring biosensor towards first in human clinical testing.
Dr. Kastellorizios’ current research focus is the translation of anticancer medicines from preclinical development to the clinic. In particular, we are developing a method for personalized treatment of metastatic breast cancer, and we are studying breast cancer health disparities in African American women as they apply to nanotherapy outcomes. In addition, he works on regulatory science to develop novel quality testing methods for nanoparticle drug products.